Search clinical trials for: 0.1% Uracil Cream

Total 7548 results

AstraZeneca
Fougera Pharmaceuticals Inc.

Withdrawn

A Proof of Concept Study With 0.5% Roflumilast Cream in Patients With Mild to Moderate Plaque Psoriasis

Plaque Psoriasis
Serentis Ltd.

Completed

Phase IIa Safety and Efficacy Study of SRD174 Cream in Patients With AD-associated Pruritus

Pruritus, Atopic Dermatitis

United States
Bonti, Inc.

Completed

Study of EB-001 in Facial Scar Reduction

Mohs Surgery

United States
Claris Biotherapeutics, Inc.

Recruiting

Study to Evaluate the Safety and Efficacy of CSB-001 Ophthalmic Solution 0.1% in Subjects With Corneal Scars

Corneal Scar

United States
Topaz Pharmaceuticals Inc

Completed

A Study Comparing the Safety and Efficacy of 0.5% Ivermectin Cream to Placebo in Lice Infested Subjects (LICE OUT)

Head Lice

United States
LEO Pharma

Completed

A Trial to Assess the Effect of Delgocitinib Cream 20 mg/g on the Molecular Signature, Safety, and Efficacy in Adults With Frontal Fibrosing Alopecia

Frontal Fibrosing Alopecia

United States
Arcutis Biotherapeutics, Inc.

Completed

Trial of PDE4 Inhibition With Roflumilast for the Management of Atopic Dermatitis (INTEGUMENT-II)

Atopic Dermatitis Eczema

United States, Canada
Incyte Corporation

Completed

A Study of INCB018424 Phosphate Cream in Subjects With Vitiligo

Vitiligo

United States
AmDerma
International Dermatology Research, Inc.

Completed

Safety and Efficacy Study Comparing AM001 Cream, 7.5% to Vehicle Cream in the Treatment of Plaque Psoriasis

Plaque Psoriasis

Dominican Republic
Calm Water Therapeutics LLC
Andover Research Eye Institute

Completed

Evaluation of the Tolerability and Efficacy of CWT-f-002 Lubricant Eye Drops

Dry Eye Disease

United States
Stiefel, a GSK Company

Completed

A Single Dose Phase I Exploratory Study in Healthy Volunteers With GSK2894512 Cream

Dermatitis, Atopic

United States
Boston Pharmaceuticals

Completed

Study to Evaluate the Safety and Antipsoriatic Efficacy of BOS-475 in a Psoriasis Plaque Test

Chronic Plaque Psoriasis

Germany
Angelos Kassianos
German Oncology Center, Cyprus; RSL Revolutionary Labs Ltd

Not yet recruiting

Prevention of Radiodermatitis in Breast and Head and Neck Cancer Patients in Cyprus (MEDISKIN)

Breast Cancer | Head and Neck Cancer

Cyprus
Sixera Pharma

Recruiting

A Study to Evaluate Topically Applied SXR1096 Cream in Patients With Netherton Syndrome

Netherton Syndrome

France
AstraZeneca
Fougera Pharmaceuticals Inc.

Withdrawn

A Placebo Controlled 4 Week Proof of Concept Study With 0.5% Roflumilast Cream in Patients With Mild Atopic Dermatitis (RO-2351-001-EM)

Dermatitis
U.S. Army Medical Research and Development Command

Completed

Pharmacokinetics, Safety, and Efficacy Trial of WR 279,396 (Paromomycin + Gentamicin Topical Cream) and Paromomycin Topical Cream for the Treatment of Cutaneous Leishmaniasis in Panama

Leishmaniasis, Cutaneous

Panama
Ark Biosciences Inc.
Shanghai Ark Biopharmaceutical Co., Ltd.

Not yet recruiting

A Study to Evaluate the Safety, Tolerability and Efficacy of AK3280 Cream on Hypertrophic Scar

Hypertrophic Scar

China
Crown Laboratories, Inc.

Completed

A Six Week Topical Cream Study for Subjects With Ichthyosis Vulgaris

Ichthyosis Vulgaris

United States
BioCis Pharma Ltd

Completed

Investigation of the Efficacy of 2.5% and 5% Cis-urocanic Acid in Patients With Moderate or Severe Atopic Dermatitis

Atopic Dermatitis

Finland
Incyte Corporation

Completed

A Study to Evaluate the Mechanism of Action of Ruxolitinib Cream in Subjects With Vitiligo (TRuE-V MOA)

Vitiligo

United States, Canada, France
Incyte Corporation

Completed

Topical Ruxolitinib Evaluation in Atopic Dermatitis Study 1 (TRuE AD1) - An Efficacy and Safety Study of Ruxolitinib Cream in Adolescents and Adults With Atopic Dermatitis

Atopic Dermatitis

United States, France, Canada, Hungary, Poland, Germany, Italy
Incyte Corporation

Completed

TRuE AD2 - An Efficacy and Safety Study of Ruxolitinib Cream in Adolescents and Adults With Atopic Dermatitis

Atopic Dermatitis

United States, Germany, Spain, Canada, Poland, Czechia, Bulgaria
Prove pharm

Recruiting

Indigotindisulfonate Sodium Injection, USP as an Aid in the Determination of Ureteral Patency

Ureter Injury

United States
Shaperon

Completed

A Phase II Study of HY209 Gel for Atopic Dermatitis Patients (Shaperon)

Atopic Dermatitis

Korea, Republic of
Kwang Dong Pharmaceutical co., ltd.

Completed

A Phase 2 Study to Compare the Efficacy and Tolerability of Tarafenacin 0.2 mg and Tarafenacin 0.4 mg to Placebo in Patients Suffering From Overactive Bladder.

Overactive Bladder

Korea, Republic of
Dr.dr.Irma Bernadette, SpKK (K)

Recruiting

Effectivity and Safety of Combination of Spent Grain Wax, Argan Oil, Shea Butter and Saccharide Isomerate

Acne Vulgaris

Indonesia
Dr. Reddys Laboratories, SA

Completed

Active-Controlled Study to Assess the Efficacy and Safety of DFD-05 in Subjects With Common Warts

Common Warts

United States
Higher School of Applied Sciences (VIST)
Abies Labs d.o.o.

Completed

Influence of of Cream With the Silver Fir Wood Extract (Belinal) on Skin

Skin Care | Wrinkles | Ageing | Photoprotection | Skin Cream
Rock Creek Pharmaceuticals, Inc.

Completed

A Study to Evaluate the Safety, Tolerability, and Effects of Anatabloc® Crème in Rosacea

Rosacea

United States
Revotar Biopharmaceuticals AG

Completed

Safety and Efficacy Study of Bimosiamose Cream to Treat Psoriasis

Psoriasis

Germany
Sol-Gel Technologies, Ltd.

Completed

MUSE Study to Evaluate the Pharmacokinetics, Safety and Tolerability of S6G5T-3

Acne Vulgaris

United States
Laboratorios Sophia S.A de C.V.

Completed

Phase IV Clinical Study to Compare the Efficacy of the Ophthalmic Solution Humylub Ofteno® PF With Hyabak® and Lagricel Ofteno® PF as Treatment for Dry Eye. (PRO-087)

Dry Eye

Mexico
Actavis Inc.
Teva Pharmaceuticals USA

Completed

Study to Evaluate Equivalence of Estradiol Vaginal Cream 0.01% to Estrace® Cream 0.01% in Atrophic Vaginitis

Atrophic Vaginitis

United States
Therapeutics, Inc.

Completed

A Comparison Study of UHE-103 Cream in Subjects With Moccasin Type Tinea Pedis

Tinea Pedis

United States, Puerto Rico
University Hospital, Lille

Completed

Interscalene Block and Dysfunction Diaphragmatic (NUMEROBIS)

Diaphragmatic Paralysis

France
Prove pharm

Recruiting

Indigotindisulfonate Sodium Injection, USP as an Aid in the Determination of Ureteral Patency in Patient's With Renal Impairment

Ureter Injury

United States
DS Biopharma

Completed

Safety and Efficacy Study of Topically Applied DS107 Cream in Mild to Moderate Atopic Dermatitis Patients (AD)

Atopic Dermatitis

United States, Canada, South Africa
Allergan

Completed

Dapsone Gel 5% and Tazarotene Cream 0.1% Versus Tazarotene Cream 0.1% Monotherapy for Facial Acne Vulgaris

Acne Vulgaris

United States
Causeway Therapeutics

Recruiting

Efficacy and Safety of TenoMiR in Lateral Epicondylitis

Tennis Elbow

United Kingdom
Moberg Pharma AB

Completed

Skin Irritation Potential of MOB015B in Healthy Subjects Using a Cumulative Irritant Patch Test Design (CIPT)

Erythema

United States
Dermavant Sciences GmbH

Completed

Tapinarof for the Treatment of Atopic Dermatitis in Children and Adults

Atopic Dermatitis

United States, Canada
Dermavant Sciences GmbH

Completed

Tapinarof for the Treatment of Atopic Dermatitis in Children and Adults (DMVT-505-3102)

Atopic Dermatitis

United States, Canada
Petra Larmo
Cliniscan Ltd

Terminated

Effects of a Berry Oil Cream on Atopic Eczema and Skin

Atopic Dermatitis Eczema

Finland
Promius Pharma, LLC

Completed

Eight Week Study of Treatment With DFD-07 for Actinic Keratosis of the Face and Scalp

Actinic Keratosis

Germany
Incyte Corporation

Completed

A Maximum Use Trial of Ruxolitinib Cream in Adolescent and Adult Participants With Atopic Dermatitis

Atopic Dermatitis

United States, Canada
LEO Pharma

Completed

Safety, Tolerability and Pharmacokinetics in AD Subjects and Healthy Subjects of Cutaneous Application of LEO 39652 Cream

Atopic Dermatitis

United Kingdom
Incyte Corporation

Recruiting

A Study to Evaluate the Efficacy, and Safety Study of Ruxolitinib Cream in Adults With Moderate Atopic Dermatitis (TRuE-AD4)

Atopic Dermatitis

Germany, Poland, United States, Spain, United Kingdom, Italy, Belgium, Canada, Netherlands, Australia, Bulgaria, France, Switzerland, Hungary, Korea, Republic of
Haus Bioceuticals

Completed

A Study to Evaluate the Efficacy and Safety of HAT01H in Atopic Dermatitis

Eczema | Atopic Dermatitis

India
Technische Universität Dresden

Completed

Comparison of Skin Thickness Under Treatment With Pimecrolimus 1% Cream, Hydrocortisonacetat 1% Cream, Betamethasonvalerat 0,1% Cream and Clobetasol-17-propionat 0,05% Cream Assessed by Optical Coherence Tomography (OCT) and 20-MHZ Ultrasound (OCT)

Healthy

Germany
Bitop AG

Completed

Efficacy and Safety of an Ectoine-containing Cream in the Treatment of Mild to Moderate Atopic Dermatitis

Mild to Moderate Atopic Dermatitis

Germany

3

Subscribe